Investors

Liftt SpA

  • Italian VC
  • Headed by Stefano Buono, founder of AAA (acquired by Novartis for $3.9bn)

Prof. Guido Costamagna

  • A major Keyron investor and supporter, widely regarded as one of the most influential figures in the history of endoscopic surgery; led pivotal trials for POSE, EndoBarrier, and other landmark metabolic devices
  • Brings deep expertise in clinical practice, design, and strategy for first-in-class endoscopic therapies—highly relevant to ForePass.

Prof. Carel Le Roux

  • Among most cited professors worldwide in obesity & diabetes
  • H-index > 70

Carl D. Francis

CEO

  • Raised >$300m
  • Led P2i from startup to world leader
  • Former Eyoto CEO
  • Significant exit and M&A experience

Dr Tareck Saleh

  • Pioneer in bariatric endoscopy with more than 3,500 gastric balloon procedures in 22 years
  • Owner of renowned weight loss clinics in Dubai & Paris

Nicolaas Verheem

  • Engineer & Founder of Teradek (acquired by Vitec for $35m)
  • Academy Technical Oscar award winner

Garvey Ventures Inc.

  • Founded by John Garvey, an experienced entrepreneur and life sciences investor

Boden Family Investments LLC

  • Founded by Dr Scott Boden, a renowned Professor of Surgery and award-winning researcher

JAZ Chemical Pathologists Ltd

  • Led by Dr Royce Vincent of King’s College London

Pioneer Medical Supplies LLC

  • Leading Middle East distributor of Medical Supplies

+ other investors

Media

Facebook Twitter Youtube Linkedin

Quick Links

Contact Us

© Copyright Keyron 2025.  All Rights Reserved.

Chris Rowland

Chairman

  • Led high-growth MedTech companies acquired by Covidien/Medtronic and Teleflex in transactions exceeding $1.9B
  • $1B+ revenue from 20+ MedTech patents
  • 17 years at Boston Scientific
Chris Rowland is one of the most accomplished leaders in the global MedTech industry, with more than 35 years of experience driving innovation, execution, and strategic growth—particularly in Class III endoscopic and metabolic devices. He served as President at Given Imaging and CEO of Neotract, playing pivotal roles during critical phases of commercial growth, clinical adoption, and strategic positioning that preceded their acquisitions by Covidien (now Medtronic) for $860M and Teleflex for $1.1B, respectively.

Chris also spent 17 years in senior leadership roles at Boston Scientific, where he developed cross-functional expertise across R&D, operations, market development, and global strategy. A prolific inventor with over 20 medical device patents generating more than $1 billion in commercial revenue, his career reflects a unique ability to translate clinical innovation into scalable business success.

As Chairman of Keyron’s Board of Directors, Chris supports corporate development, fundraising, and strategic execution—bringing hands-on leadership and global perspective to help scale ForePass into a category-defining solution in metabolic health.